search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
24 PEPTIDES


activity. In 2D cultures, the bioactive peptide at


0.25–2.0 mg/mL increased pro-C1 secretion by 2.8–3.4-fold over 24 hours. For comparison, TGFβ increased secretion by 1.9-fold, while vitamin C alone boosted it 4.9-fold. Retinoic acid (RA) and hyaluronic acid (HA) showed no significant effects. Combining the bioactive peptide with 50


µg/mL of vitamin C further amplified collagen secretion. Over 24 hours, this combination increased pro-C1 levels 9.8–11.3-fold. Longer- term measurements at 72 and 120 hours showed sustained increases of 1.4–2.5-fold and 2.6–4.5- fold, respectively. These results suggest that vitamin C can


enhance the bioactive peptide’s effect, promoting prolonged collagen secretion and potentially supporting firmer, more resilient skin over time.


Stimulating collagen production in skin cells Beyond secretion, the bioactive peptide actively enhances intracellular collagen levels. Research shows that the bioactive peptide encourages fibroblasts to both produce and secrete collagen over extended periods. Type I collagen, the most abundant collagen


in skin, provides structural support, while Type III collagen contributes to skin elasticity. The amount of collagen protein in cells reflects how much is actually available for tissue repair, while mRNA levels indicate the gene activity behind its production. Increasing these levels can help improve skin firmness, reduce wrinkles, and support healing. In lab studies, treatment with 0.25 mg/mL


bioactive peptide increased intracellular Type I collagen and Type III collagen by 1.4-fold and 2.2-fold, respectively, while higher doses trended toward baseline. This shows that the bioactive peptide enhances collagen secretion while


Untreated


Epidermis SC SB


Papillary Dermis


Reticular Dermis


Untreated ■ 2 mg/mL 27P peptide-AF594 ■ 10 mg/mL 27P peptide-AF594 ■ 120 100


80 30


20 10 0


*


Basal Keratinocytes ****


Papillary Dermis 120 100 *


80 30


*


20 10 0


24h (No VC)


24h + 72h (With VC)


* *** 24h (No VC)


24h + 72h (With VC)


Figure 1: Quantification of 27P peptide penetration in 3D skin model


maintaining internal collagen stores — a sign of active new collagen synthesis. For comparison, TGFβ and HA also boosted


intracellular collagen, whereas RA and vitamin C reduced it, likely because increased secretion depleted internal stores faster than cells could produce new collagen. Remarkably, the bioactive peptide was able


to reverse vitamin C-induced collagen loss, increasing Type I collagen 4.3-fold and Type III collagen 11.1-fold. Across a range of doses, the bioactive peptide raised Type I collagen 1.4–2.0-fold and Type III collagen 2.2–2.3-fold at higher doses, highlighting its ability to support intracellular collagen even when other compounds deplete it.


These findings suggest that the bioactive


peptide works through a mechanism distinct from traditional actives, targeting the translation


2 mg/mL 27P peptide-AF594


of collagen rather than its gene expression. By helping skin cells produce and maintain collagen efficiently, the bioactive peptide shows strong potential as a next-generation ingredient for firmer, more resilient skin.


Boosting collagen production and remodeling in skin cells Collagen deposition into the extracellular matrix is critical for skin strength and elasticity. Research shows that the bioactive peptide helps dermal fibroblasts both secrete and deposit collagen into the extracellular matrix. When fibroblasts were treated with 0.25 mg/


mL bioactive peptide, total collagen deposition increased by 12% after three days and 19% after five days, comparable to the effects of the well- known growth factor TGFβ. Increasing the dose to 1.0 mg/mL boosted collagen deposition even


10 mg/mL 27P peptide-AF594


ZOOM


20 10 0


ns * ** 120 100


80 30


ns ns


Reticular Dermis ***


24h (No VC)


24h + 72h (With VC)


Figure 2: Q27P peptide penetration through intact epidermis in 3D skin model in 24h PERSONAL CARE MAGAZINE January 2026 www.personalcaremagazine.com


10 mg/mL 27P peptide-AF594


2 mg/mL 27P peptide-AF594


Untreated


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72